UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Why Cancer?

PharmacoEconomics, 2016-07, Vol.34 (7), p.625-627

Haycox, Alan

2016

Link zum Volltext

Verfügbarkeit prüfen

Real-world costs of transvenous lead extraction: the challenge for reimbursement

Europace (London, England), 2019-02, Vol.21 (2), p.290-297

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers

BMC health services research, 2010-06, Vol.10 (1), p.153-153, Article 153

2010

Link zum Volltext

Verfügbarkeit prüfen

Should Low- and Middle-Income Countries Adopt Clinical Guidelines Developed in ‘Rich’ Countries?

PharmacoEconomics, 2018-07, Vol.36 (7), p.731-732

Haycox, Alan

2018

Link zum Volltext

Verfügbarkeit prüfen

Quantifying the relationship between disability progression and quality of life in patients treated for NMOSD: Insights from the SAkura studies

Multiple sclerosis and related disorders, 2022-01, Vol.57, p.103332-103332, Article 103332

2022

Link zum Volltext

Verfügbarkeit prüfen

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

Frontiers in pharmacology, 2017-08, Vol.8, p.497-497

2017

Link zum Volltext

Verfügbarkeit prüfen

The Induction with Foley OR Misoprostol (INFORM) Study dataset. A dataset of 602 women with hypertensive disease in pregnancy, in India, randomised to either Foley catheter or oral misoprostol for induction of labour

BMC research notes, 2021-09, Vol.14 (1), p.355-355, Article 355

2021

Link zum Volltext

Verfügbarkeit prüfen

A Single-Center Randomized Trial of Intraoperative Zero-Balanced Ultrafiltration During Cardiopulmonary Bypass for Patients With Impaired Kidney Function Undergoing Cardiac Surgery

Journal of cardiothoracic and vascular anesthesia, 2015-10, Vol.29 (5), p.1236-1247

2015

Link zum Volltext

Verfügbarkeit prüfen

Optimizing Decision Making and Resource Allocation in Palliative Care

Journal of pain and symptom management, 2009-07, Vol.38 (1), p.45-53

Haycox, Alan, BA, MA, PhD

2009

Link zum Volltext

Verfügbarkeit prüfen

How Much Should the NHS Pay for a QALY?

PharmacoEconomics, 2013-05, Vol.31 (5), p.357-359

Haycox, Alan

2013

Link zum Volltext

Verfügbarkeit prüfen

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature

Health economics, 2001-10, Vol.10 (7), p.601-615

2001

Link zum Volltext

Verfügbarkeit prüfen

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications

PharmacoEconomics, 2017-12, Vol.35 (12), p.1271-1285

2017

Link zum Volltext

Verfügbarkeit prüfen

An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review

Pharmacogenomics, 2017-11, Vol.18 (16), p.1541

2017

Link zum Volltext

Verfügbarkeit prüfen

Optimizing Decision Making and Resource Allocation in Palliative Care : Advancing the health economics of palliative care

Journal of pain and symptom management, 2009, Vol.38 (1), p.45-53

HAYCOX, Alan

2009

Link zum Volltext

Verfügbarkeit prüfen

Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study

The Lancet infectious diseases, 2018-09, Vol.18 (9), p.992-1003

2018

Link zum Volltext

Verfügbarkeit prüfen

Does ‘NICE blight’ exist, and if so, why?

PharmacoEconomics, 2008-01, Vol.26 (12), p.987-989

Haycox, Alan

2008

Link zum Volltext

Verfügbarkeit prüfen

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial

The Lancet (British edition), 2017-08, Vol.390 (10095), p.669-680

2017

Link zum Volltext

Verfügbarkeit prüfen

Through a Glass Darkly: Economics and Personalised Medicine

PharmacoEconomics, 2014-11, Vol.32 (11), p.1055-1061

2014

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab uptake in HER2-positive breast cancer patients: a systematic review and meta-analysis of observational studies

Critical reviews in oncology/hematology, 2018-10, Vol.130, p.92-107

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models

PharmacoEconomics, 2005-01, Vol.23 Suppl 1 (S1), p.3-16

Haycox, Alan

2005

Link zum Volltext

Verfügbarkeit prüfen

Enhancing the rational use of new medicines across European health care systems

European journal of clinical pharmacology, 2008-12, Vol.64 (12), p.1137-1138

2008

Link zum Volltext

Verfügbarkeit prüfen

When NICE says no

PharmacoEconomics, 2007, Vol.25 (12), p.995-996

Haycox, Alan

2007

Link zum Volltext

Verfügbarkeit prüfen

Personalizing health care: feasibility and future implications

BMC medicine, 2013-08, Vol.11 (1), p.179-179, Article 179

2013

Link zum Volltext

Verfügbarkeit prüfen

Patent expiry and costs for anticancer medicines for clinical use

GaBI Journal, 2017-09, Vol.6 (3), p.105-106

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Englisch
(111)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Why Cancer?

Real-world costs of transvenous lead extraction: the challenge for reimbursement

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers

Should Low- and Middle-Income Countries Adopt Clinical Guidelines Developed in ‘Rich’ Countries?

Quantifying the relationship between disability progression and quality of life in patients treated for NMOSD: Insights from the SAkura studies

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

The Induction with Foley OR Misoprostol (INFORM) Study dataset. A dataset of 602 women with hypertensive disease in pregnancy, in India, randomised to either Foley catheter or oral misoprostol for induction of labour

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways

A Single-Center Randomized Trial of Intraoperative Zero-Balanced Ultrafiltration During Cardiopulmonary Bypass for Patients With Impaired Kidney Function Undergoing Cardiac Surgery

Optimizing Decision Making and Resource Allocation in Palliative Care

How Much Should the NHS Pay for a QALY?

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications

An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review

Optimizing Decision Making and Resource Allocation in Palliative Care : Advancing the health economics of palliative care

Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study

Does ‘NICE blight’ exist, and if so, why?

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial

Through a Glass Darkly: Economics and Personalised Medicine

Trastuzumab uptake in HER2-positive breast cancer patients: a systematic review and meta-analysis of observational studies

Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models

Enhancing the rational use of new medicines across European health care systems

When NICE says no

Personalizing health care: feasibility and future implications

Patent expiry and costs for anticancer medicines for clinical use

Suchergebnisse filtern